Skip to main content
For professional inquiries, please contact us: reynolds_science_inquiries@rjrt.com
Reynolds Science REYNOLDS - A Better Tomorrow - Logo
  • Tobacco Harm Reduction
  • Smokeless Products
  • Our Science
    • Framework
    • Analytical Science
    • Pre-Clinical
    • Individual Health
    • Population Health
  • Let’s Connect
    • Conferences
  • Library
  • Tobacco Harm Reduction
  • Smokeless Products
  • Our Science
    • Framework
    • Analytical Science
    • Pre-Clinical
    • Individual Health
    • Population Health
  • Let’s Connect
    • Conferences
  • Library
For professional inquiries, please contact us: reynolds_science_inquiries@rjrt.com
science

Individual & Population Health

FPO

Jun 12th 2023

Purchase Intent and Appeal of ENDS Products among Current, Former and Never Ever Users of Tobacco Products in the U.S.

Jun 1st 2023

Part two: an unblinded, parallel, randomized study to assess nicotine pharmacokinetics of four Vuse Solo ENDS flavors in smokers

Mar 27th 2023

Biomarkers of Exposure and Potential Harm in Two Weeks of Smoking Abstinence: Changes in Biomarkers of Platelet Function, Oxidative Stress, and Inflammation

Mar 1st 2023

A systematic review of RCTs to examine the risk of adverse cardiovascular events with nicotine use

Dec 21st 2022

Part one: abuse liability of Vuse Solo (G2) electronic nicotine delivery system relative to combustible cigarettes and nicotine gum

Nov 30th 2022

Part three: a randomized study to assess biomarker changes in cigarette smokers switched to Vuse Solo or Abstinence

Aug 19th 2022

Designing Studies to Inform Tobacco Harm Reduction: Learnings From an Oral Nicotine Pouch Actual Use Pilot Study

Nov 27th 2021

Reporting and methodological quality of systematic literature reviews evaluating the associations between e-cigarette use and cigarette smoking behaviors: a systematic quality review

Sep 9th 2021

Human Abuse Liability Assessment of Tobacco and Nicotine Products: Approaches for Meeting Current Regulatory Recommendations

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next
Reynolds Science REYNOLDS - A Better Tomorrow - Logo

© 2026 RAISC.

This website is intended for scientists and policymakers. The material on this website is not provided for product advertising, promotional, or marketing purposes. We encourage persons interested in tobacco harm reduction to consider all points of view and sources of information. The Reynolds American organization does not make health claims regarding its companies’ brands. Nothing contained here should be misconstrued to the contrary. To the extent that third-party sources are referenced, the Reynolds American organization is not responsible for the content of referenced sources and the views expressed may not represent the views of the Reynolds American organization. No tobacco product is safe, all tobacco products containing nicotine are addictive. Underage persons should never use tobacco. Smokers who are concerned about their health should quit.

Reynolds American Inc. is the U.S. parent company of, among others, R. J. Reynolds Tobacco Company; Santa Fe Natural Tobacco Company, Inc.; American Snuff Company, LLC; R. J. Reynolds Vapor Company; Modoral Brands Inc.; RAI Services Company; and Reynolds Marketing Services Company. All subsidiaries operate and conduct separate, distinct businesses. References to “Reynolds,” “the group,” “the company,” “the organization,” “we,” “us,” and “our” are simply for convenience and may be used to refer to Reynolds American Inc. and/or one of its independent subsidiary operating companies, collectively or individually, and are not intended to imply or suggest that the subsidiaries’ businesses are operated other than as separate, distinct businesses. Activities among affiliate companies are covered through intercompany services agreements with arm's-length terms and conditions.

  • Terms of Use
  • Member of the Global BAT Group